Robert (Bob) Nelsen (ARCH Venture Partners)

Nelsen, Robert (Bob) (ARCH Venture Partners 2020 Managing Director + Co-Founder in 1986)

	Organisation	ARCH Venture Partners
	Group	ARCH Venture (Group)
	Former/major organisation	Vir Biotechnology Inc. (Nasdaq: VIR)
	Group	Vir Biotechnology (Group)
	Product	venture capital
	Product 2	LIFE SCIENCES

Record changed: 2024-10-11

Picture Kenes Exhibitions Biomed Israel 2025 Tel Aviv 650x200px

More documents for Robert (Bob) Nelsen

[1] Seaport Therapeutics. (4/9/24). "Press Release: Seaport Therapeutics Launches with $100 Million Oversubscribed Series A Financing Round to Advance Novel Neuropsychiatric Medicines". Boston, MA....
[2] Paradigm Health, Inc.. (1/25/23). "Press Release: Paradigm Launches with $203 Million to Rebuild the Clinical Research Ecosystem". New York, NY....
[3] Akamis Bio Ltd.. (1/5/23). "Press Release: Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics". Cambridge, MA & Oxford....
[4] ARCH Venture Partners. (4/2/20). "Press Release: ARCH Venture Partners Announces $1.46 Billion Raised in Two New Funds to Invest in Transformative Biotechnology Companies"....
[5] Sonoma Biotherapeutics Inc.. (2/6/20). "Press Release: Sonoma Biotherapeutics Launches with $40 Million in Series A Funding to Advance Regulatory T Cell Therapy in Autoimmune and Degenerative Diseases"....
[6] Karuna Therapeutics, Inc.. (3/18/19). "Press Release: Karuna Announces $68 Million Series B Financing". Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]